Cocrystal Pharma Inc (COCP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $18.88M
Last updated: Nov 17, 2026 at 10:48 AM ET
Cocrystal Pharma Inc (COCP) Competitors
The companies most similar to Cocrystal Pharma are Cyclerion Therapeutics (CYCN), NextCure (NXTC) and Estrella Immunopharma (ESLA). By market cap, Cocrystal Pharma ranks 8th of the 13 companies on this page; Quince Therapeutics (QNCX) is the largest at $32.27M.
Peer Comparison
COCP's revenue growth of 26.9% is above the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Cocrystal Pharma (COCP) | $18.88M | N/A | 39.2x | 0.0% | N/A | 26.9% | 0.00% |
| Cyclerion Therapeutics Inc (CYCN) | $15.73M | N/A | N/A | 0.0% | N/A | -43.2% | 0.00% |
| NextCure Inc (NXTC) | $29.31M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Estrella Immunopharma Inc. (ESLA) | $22.36M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Transcode Therapeutics Inc (RNAZ) | $22.35M | N/A | N/A | 0.0% | -412.7% | 0.0% | 0.00% |
| Citius Pharmaceuticals Inc (CTXR) | $14.69M | N/A | 1.9x | 0.0% | -84.3% | 0.0% | 0.00% |
| Plus Therapeutics Inc (PSTV) | $26.64M | N/A | 2.0x | -230.2% | -827.8% | -2.9% | 0.00% |
| Quoin Pharmaceuticals Ltd DRC (QNRX) | $17.78M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| NanoViricides Inc (NNVC) | $31.41M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Context Therapeutics Inc (CNTX) | $16.61M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| CEL-SCI Corp (CVM) | $22.51M | N/A | N/A | 0.0% | -109.0% | -62.7% | 0.00% |
| Akari Therapeutics PLC (AKTX) | $15.54M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Quince Therapeutics, Inc. (QNCX) | $32.27M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $22.35M | N/A | 2.0x | 0.0% | -260.9% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Cocrystal Pharma, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Cyclerion Therapeutics Inc (CYCN) | Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery, development... | |
| NextCure Inc (NXTC) | NextCure, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of novel immunomedicines to treat cancer and other... | NXTC competitors |
| Estrella Immunopharma Inc. (ESLA) | Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. | ESLA competitors |
| Transcode Therapeutics Inc (RNAZ) | TransCode Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development and commercialization of drugs for the treatment of metastatic... | RNAZ competitors |
| Citius Pharmaceuticals Inc (CTXR) | Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets critical care products. | CTXR competitors |
| Plus Therapeutics Inc (PSTV) | Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing... | PSTV competitors |
| Quoin Pharmaceuticals Ltd DRC (QNRX) | Quoin Pharmaceuticals Ltd (QNRX) is an innovative biotechnology firm dedicated to developing cutting-edge therapeutics for rare diseases... | QNRX competitors |
| NanoViricides Inc (NNVC) | NanoViricides, Inc., a nanobiopharmaceutical company, discovers, develops and markets drugs for the treatment of viral infections. | NNVC competitors |
| Context Therapeutics Inc (CNTX) | Centrexion Therapeutics Corporation, a late-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel, non-opioid... | CNTX competitors |
| CEL-SCI Corp (CVM) | CEL-SCI Corporation is dedicated to the research and development of immunotherapy for the treatment of cancer and infectious diseases. | CVM competitors |
| Akari Therapeutics PLC (AKTX) | Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of treatments for autoinflammatory... | AKTX competitors |
| Quince Therapeutics, Inc. (QNCX) | Quince Therapeutics, Inc., a biopharmaceutical company, is focused on advancing precision therapies for rare and debilitating diseases. |
Frequently Asked Questions About COCP
Who are Cocrystal Pharma's main competitors?
The companies most similar to Cocrystal Pharma include Cyclerion Therapeutics (CYCN), NextCure (NXTC), Estrella Immunopharma (ESLA), Transcode Therapeutics (RNAZ) and Citius Pharmaceuticals (CTXR), listed from the closest match.
Who is Cocrystal Pharma's biggest competitor?
Quince Therapeutics (QNCX) is the largest of the similar companies at $32.27M; Cyclerion Therapeutics (CYCN) is the closest match by business profile, size, sector and industry.
How does COCP stock compare with its competitors?
COCP's P/S is 39.2x against a peer median of 2.0x; its net margin is 0.0% against a peer median of 0.0%.
Which of Cocrystal Pharma's competitors pays a higher dividend?
Cocrystal Pharma pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Cocrystal Pharma bigger than its competitors?
No. Cocrystal Pharma is 8th by market cap among the 13 companies on this page; the largest is Quince Therapeutics (QNCX) at $32.27M.
COCP pages: Overview, Earnings, Forecast, Financials, Competitors, Government Contracts